• Title/Summary/Keyword: juice carrier

검색결과 6건 처리시간 0.018초

JUICE CARRIER 냉동 CARGO HOLD INSULATION 설계에 대한 연구 (A Study of refrigerator cargo hold insulation design for Juice carrier ship)

  • 홍창희;이종태;박태하
    • 대한조선학회 특별논문집
    • /
    • 대한조선학회 2015년도 특별논문집
    • /
    • pp.20-27
    • /
    • 2015
  • The juice carrier is the first ship built in korea. Special refrigerator system and cargo hold insulation with stainless steel tank were equipped on cargo hold. We studied optimum design of cargo hold insulation for reducing of ship building schedule and cost including good quality with refrigerating efficiency. From this study, general and newly specified juice carrier, technical method of cargo hold insulation system, air flow with division air wall, K-value calculation have been investigated.

  • PDF

알긴산나트륨 마트릭스로부터 플루오로우라실의 제어 방출 (Controlled Release of Fluorouracil from Sodium Alginate Matrices)

  • 김성호;정용재;하정헌
    • Journal of Pharmaceutical Investigation
    • /
    • 제22권2호
    • /
    • pp.149-153
    • /
    • 1992
  • The applicability of sodium alginate as a carrier of 5-fluorouracil as an oral delivery system was investigated. Hydrophobicity of sodium alginate was controlled by introducing cetyl group to this polymer. The effects of degree of esterification for n-cetyl partial ester on the rate of release of 5-fluorouracil in artificial gastric juice and artificial intestinal juice were examined. The release rete of the drug in the gastric juice was mainly affected by the diffusion of the drug. The release rate of the drug in the intestinal juice could be controlled by the degree of esterification. The alginate matrices may be a valuable addition as the carrier of 5-fluorouracil for an oral delivery system.

  • PDF

분무건조에 의한 분말대추음료의 가공 (Processing of Powdered Jujube Juice by Spray Drying)

  • 안덕순;우강융;이동선
    • 한국식품영양과학회지
    • /
    • 제26권1호
    • /
    • pp.81-86
    • /
    • 1997
  • 대추를 이용한 가공제품의 하나로서 분무건조에 의한 분말음료의 개발을 시도하였다. 대추 추출액은 그 자체로는 모든 농도 범위에서 분무건조 하기가 불가능하였고 건조보조제의 첨가에 의해서 분말음료로의 제조가공이 가능하였다 대추 추출액은 26。Bx 농도까지 농축시키고 알맞은 건조보조제를 첨가하여 최종농도를 30。Bx로 조정하여 분무 건조시켰다 첨가되는 건조보조제의 양은 대추 추출액과 건조보조제의 비율이고 형물 기준으로 1:1정도까지 흔합했을때 건조가 용이하고 얻어지는 제품의 품질이 양호하였다. maltose, 농축유, gum arabic, dextrin등의 건조보조제를 검토한 결과 maltose와 gum arabic을 흔합하여 사용할 때 제품의 관능적 특성이 가장 우수하였다. 대추 추출시의 효소처리는 수율을 13~39% 향상시 킬 수 있었다. 그렇지만 효소처리가 분말대추음료의 관능적인 특성에 부정적인 영향을 나타내었으며 추출수율 향상을 위해 사용되어진다면 품질열화가 적은 pectinase의 0.5% 처리가 가장 바람직한 것으로 나타났다.

  • PDF

Phenotyping of Flavin-Containing Monooxygenase (FMO) Activity and Factors Affecting FMO Activity in Korean

  • Jeon, Sun-Ho;Park, Chang-Shin;Cha, Young-Nam;Chung, Woon-Gye
    • Toxicological Research
    • /
    • 제17권
    • /
    • pp.127-133
    • /
    • 2001
  • Together with cytochrome P450 (CYP), flavin-containing monooxygenase (FMO) present in liver microsomes oxidizes various endogenous and exogenous chemicals. In an effort to determine the human FMO activity, we have developed two non-invasive urine analysis methods using caffeine (CA) and ranitidine (RA) as the probe compounds. As the production of theobromine (TB) and ranitidine N-oxide (RANO) from CA and RA is catalyzed primarily by the hepatic FMO, we have assigned the urinary molar ratios of TB/CA and RA/RANO as the in vivo FMO activity. In 200 age-matched Korean volunteers, the obtained TB/CA ratio ranged from 0.4 to 15.2 (38-fold difference) and the RA/RANO ratio from 5.7 to 27.2 (4.8-fold). The FMO activity of 20's, determined by caffeine metabolism, was the highest (2.5$\pm$l.9) and those of 30's, 40's, 50's, 60's and 70's were 40%, 50%, 24%, 39% and 36% of the 20's, respectively. Intake of grapefruit juice, known to contain flavonoids, inhibited the in vivo FMO (TB/CA) activity by 79%. Addition of the flavonoids like naringin, quercitrin and kaempferol, present in grapefruit juice, to the in vitro microso-mal FMO assay, thiobenzamide S-oxidation, produced 75%, 70% and 60% inhibition, respectively. Obtained Ki values of quercitrin, kaempferol and naringin on the in vitro FMO activity were 6.2, 12.0 and 13.9 $\mu\textrm{M}$, respectively. This suggested that the dose of drug should need to be adjusted to suit the individual FMO activities when the drugs metabolized by FMO are given to patients. As the intake of grapefruit juice has been identified to inhibit the FMO as well as CYP3A4 and lA2 activities, patients taking drugs metabolized by these enzymes should not drink grapefruit juice as the carrier.

  • PDF

아세클로페낙 고체분산체의 특성 및 용출률 개선 (Characterization and Improved Dissolution Rate of Aceclofenac Solid Dispersion)

  • 김윤태;박현진;이영현;홍희경;엄신;김용기;이은용;최명규;이재준;조용백;강길선
    • 폴리머
    • /
    • 제33권6호
    • /
    • pp.596-601
    • /
    • 2009
  • 아세클로페낙은 높은 결정성을 갖는 난용성 약물이다. 이러한 난용성 약물의 용해도를 증진시키기 위해서 고체분산법을 바탕으로 한 분무건조기를 이용하여 미립구를 제조하였다. PVP-K30을 수용성 담체로 사용하였고 폴록사머는 계면활성화제로 사용하였다. 제조된 아세클로페낙 고체분산체의 특성을 SEM, DSC, XRD 그리고 FT-IR을 이용하여 확인하였다. SEM, DSC, XRD을 통하여 아세클로페낙 고체분산체가 무정형임을 알 수 있었고 FT-IR을 통하여 아세클로페낙과 PVP-K30간에 수소결합을 통해 염을 형성하고 있다는 것을 확인할 수 있었다. 제조된 미립구는 pH 6.8에서 방출을 실시하였으며 시판제인 $Airtal^{(R)}$과 용출률을 비교하였으며 분무건조를 통해 제조한 미립구가 시판제인 $Airtal^{(R)}$ 보다 용출률이 크다는 것을 확인하였다.

아토르바스타틴 칼슘 고체분산체의 특성화 및 용출율 개선 (Improved Dissolution and Characterization of Solid Dispersed Atorvastatin Calcium)

  • 이준희;구정;박정수;박종학;안식일;모종현;김윤태;이종문;이해방;강길선
    • Journal of Pharmaceutical Investigation
    • /
    • 제38권2호
    • /
    • pp.111-117
    • /
    • 2008
  • To overcome the solubility of poorly water-soluble drug, the formation of solid dispersion using a spray-dryer with polymeric material, that can potentially enhance the dissolution rate extend of drug absorption was considered in this study. $Eudragit^{(R)}$ E100 as carrier for solid dispersion is acrylate copolymer that soluble in acidic buffer solutions (below pH 5.0). It was used to increase dissolution of atorvastatin calcium as a water-insoluble drug in acidic environments. In this study, a spray-dryer was used to prepare solid dispersion of atorvastatin calcium and $Eudragit^{(R)}$ E100 for purpose of improving the solubility of drug. Atorvastatin calcium and $Eudragit^{(R)}$ E100 were dissolved in ethanol and spray-dryed. DSC and XRD were used to analyze the crystallinity of the sample. It was found that atorvastatin calcium is amorphous in the $Eudragit^{(R)}$ E100 solid dispersion. FT-IR was used to analyze the salt formation by interaction between atorvastatin calcium and $Eudragit^{(R)}$ E100. Comparative dissolution study exhibited better dissolution characteristics than the commercial drug ($Lipitor^{(R)}$) as control. The dissolution rate of atorvastatin calcium was markedly increased in solid dispersion system in simulated gastric juice (pH 1.2). This study proposed that this solid dispersion system improved the bioavailability of poorly water-soluble atorvastatin calcium.